Results

Total Results: 2,209 records

Showing results for "drug".

2021. Disposition of Comments for Evidence Report 222 Youth Suicide Prevention (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/suicide-prevention_disposition-comments.pdf
      October 04, 2016 - a study demonstrating proximal crossover effects unanticipated beneficial effects of a selective drug

2022. Disposition of Comments Technical Brief 41: Evaluation of Mental Health Mobile Applications (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/mental-health-mobile-apps-disposition-of-comments.pdf
      May 20, 2022 - stakeholders (including Federal partners: National Institute of Mental Health [NIMH], Food and Drug

2023. Amendment_HIE-Protocol_3-14-2015 (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/health-information-exchange_research-protocol.pdf
      April 20, 2015 - Methods for the drug effectiveness review project. BMC Med Res Methodol. 2012;12.

2024. Technical-Brief-31-Mobile-Health-Applications-For-Self-Management-Of-Diabetes (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/tech-brief-31-mobile-applications-self-mgmt.pdf
      May 01, 2018 - Some connect directly to US Food and Drug Administration (FDA)-approved medical devices, such as blood … transfer, license, and/or covey some or all the information collected on the platform including drug … Food and Drug Administration. … Food and Drug Administration. Letter to WellDoc regarding BlueStar 510(k) clearance. 2017.

2025. genetic-testing-developmental-disabilities-protocol-140930 (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/genetic-testing-developmental-disabilities_research-protocol.pdf
      September 30, 2014 - Food and Drug Administration (FDA) or as a laboratory-developed test (LDT).20,21 FDA-cleared or -approved … Food and Drug Administration; LDT—laboratory-developed test Source: www.effectivehealthcare.ahrq.gov

2026. White Paper_Machine Learning Tools To (Semi-)Automate Evidence Synthesis: A Rapid Review and Evidence Map (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/machine-learning-tools-white-paper.pdf
      December 01, 2024 - tool Jonnalagadda, Siddhartha, Petitti, Diana International journal of computational biology and drug … Pharmacoepidemiology and Drug Safety 31():- none Duplicate Pashos, C. … Pharmacoepidemiology and Drug Safety 31():- none Not a SR task Perlman-Arrow, S., Loo, N., Bobrovitz

2027. Digestible Carbohydrate Intake and Maternal-Infant Outcomes: A Systematic Review (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/carbohydrate-intake-draft-report.pdf
      January 31, 2025 - Food Labeling: Front-of- Package Nutrition Information: A Proposed Rule by the Food and Drug Administration … Food and Drug Administration. The Nutrition Facts Label. 2024.

2028. Topic Brief: Radiation Therapy for Bone Metastases (pdf file)
      effectivehealthcare-admin.ahrq.gov/system/files/docs/topic-brief-radiation-therapy-bone-metastases.pdf
      August 01, 2022 - Does the nomination represent a health care drug, intervention, device, technology, or health care

2029. Smoking-Pregnancy-Infants Executive (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/smoking-pregnancy-infants_executive.pdf
      February 01, 2014 - Food and Drug Administration places the transdermal nicotine patch in pregnancy category D, which indicates

2030. Glaucoma-Treatment-Appendices-11-5-10-2 (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/glaucoma-treatment-appendices-11-5-10-2.pdf
      October 27, 2009 - Confidence interval COAG Chronic open angle glaucoma EPC Evidence-based Practice Center FDA Food and Drug

2031. Disposition of Comments for Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cancer-anemia-update_disposition-comments.pdf
      April 25, 2013 - The broad AHRQ conclusion also stands in contrast to conclusions drawn by the Food and Drug Administration

2032. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_disposition-comments.pdf
      September 01, 2011 - In that study, the authors reported a significant difference in relapse rates favoring active drug ( … www.effectivehealthcare.ahrq.gov 29 early adverse events responded better to the form of CBT tested than to any drug

2033. Identifying Priorities for Patient-Centered Outcomes Research for Serious Mental Illness (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/mental-illness-priorities_research.pdf
      September 01, 2011 - Washington University Director, Center for Cross Cultural Psychology Laughren, Thomas P., MD Food and Drug

2034. Breastfeeding and Health Outcomes for Infants and Children (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/breastfeeding-health-outcomes-protocol.pdf
      February 01, 2023 - Food and Drug Administration and/or Codex Alimentarius international food standards; also referred

2035. Field Triage Guideline Revision: Glasgow Coma Scale: Systematic Review | Effective Health Care (EHC) Program
      effectivehealthcare-admin.ahrq.gov/products/field-triage-glascow/research-protocol
      February 28, 2016 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …

2036. Healthcare Industry Waste and Lifecycle Assessment | Effective Health Care (EHC) Program
      effectivehealthcare-admin.ahrq.gov/products/lifecycle-assessment
      September 21, 2023 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …

2037. Genitourinary Syndrome of Menopause | Effective Health Care (EHC) Program
      effectivehealthcare-admin.ahrq.gov/products/genitourinary-syndrome/protocol
      March 01, 2023 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …

2038. Technical Brief Disposition of Comments Report for Gene Expression Profiling for Predicting Outcomes in Stage II Colon Cancer (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/colon-cancer-gene-profiling_disposition-comments.pdf
      December 14, 2012 - therapy (across multiple effective regimens) versus prediction of benefit from a specific regimen or drug

2039. Layout 1 (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_executive.pdf
      September 01, 2011 - Layout 1 Background Major depressive disorder (MDD) is common and costly. Over the course of a year, between 13.1 million and 14.2 million people will experience MDD. Approximately half of these people seek help for this condition, and only 20 percent of those receive adequate treatment. For those who do initiate tr…

2040. Undescended-Testicle Executive (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/undescended-testicle_executive.pdf
      December 01, 2012 - studies is possibly due to heterogeneity in the study populations or potentially due to variability in drug